Vibrotactile Feedback to Improve Walking After Stroke

September 15, 2026 updated by: Geisinger Clinic

Use of Vibrotactile Feedback to Increase Propulsion in Individuals With Chronic Stroke

Stroke survivors often walk more slowly and may have difficulty producing the movements needed to walk efficiently. This study will evaluate whether vibrotactile feedback, delivered through small wearable devices that provide vibrations during walking, can help individuals with chronic stroke change specific walking movements related to walking speed, propulsion, and balance.

Participants will complete a single study visit at Bucknell University. During the visit, participants will perform several walking trials with and without vibrotactile feedback and will complete common clinical mobility and balance assessments. Motion capture technology and wearable sensors will be used to measure movement during walking.

The goal of this study is to better understand how vibrotactile feedback can be used to improve walking performance after stroke and to support the future development of rehabilitation approaches for stroke survivors.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Post-stroke gait rehabilitation frequently targets walking speed because improved walking speed is associated with greater functional mobility and community participation. Forward propulsion is strongly related to walking speed, but the biomechanical concepts commonly targeted in rehabilitation can be difficult for patients to understand and apply during walking. Vibrotactile biofeedback may provide a simple and intuitive method of promoting desirable gait modifications by delivering real-time feedback based on clinically meaningful movement parameters.

The purpose of this study is to evaluate the immediate effects of vibrotactile feedback on walking biomechanics in individuals with chronic stroke. Specifically, the study will investigate whether vibrotactile feedback can increase walking speed and forward propulsion, improve symmetry of gait-related measures, and reduce lateral trunk sway during walking. The study will also explore the use of wearable inertial measurement units (IMUs) to objectively quantify movement during common clinical mobility and balance assessments.

Participants will complete a single study visit at the Bucknell University Biomechanics Laboratory. During the visit, motion capture technology, wearable inertial measurement units, timing gates, and force plates will be used to measure walking biomechanics. Participants will complete walking trials under baseline and vibrotactile feedback conditions targeting trailing limb angle, ankle plantarflexion, and trunk sway. Participants will also complete the Timed Up and Go (TUG) assessment and the Berg Balance Scale (BBS).

The information collected in this study will be used to improve understanding of how vibrotactile feedback can influence gait biomechanics after stroke and may support future development of rehabilitation approaches intended to improve walking function and mobility in stroke survivors.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 to 85 years
  • Willing and able to provide informed consent
  • Single unilateral stroke at least 6 months prior to enrollment
  • ICD diagnosis code for hemiparesis (I69.35X)
  • Independently ambulatory (cane acceptable; orthosis may require further evaluation)
  • Resting heart rate 40 to 100 beats per minute
  • Resting blood pressure 90/60 to 170/90 mmHg
  • Active hip extension of at least 5 degrees
  • Active ankle dorsiflexion to neutral with the knee extended

Exclusion Criteria:

  • Evidence of cerebellar stroke
  • Other neurological conditions
  • Lower-limb botulinum toxin injections within the previous 4 months
  • Pain that limits walking
  • Unable to communicate with investigators
  • Signs of unilateral neglect
  • Unexplained dizziness within the previous 6 months
  • Fall within the previous 6 months
  • Congestive heart failure
  • Chronic obstructive pulmonary disease
  • Severe peripheral vascular disease
  • Score greater than 1 on question 1b of the NIH Stroke Scale
  • Score greater than 0 on question 1c of the NIH Stroke Scale
  • Currently pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vibrotactile Feedback Walking Assessment

Participants with chronic stroke will complete a single study visit that includes baseline walking assessment, vibrotactile feedback walking conditions targeting trailing limb angle, ankle plantarflexion, and trunk sway, and clinical mobility and balance assessments. All participants will complete all study conditions and serve as their own controls.

Participants will receive vibrotactile feedback using a wearable SageMotion system consisting of inertial measurement units mounted on elastic straps. The system calculates joint angles during walking and provides vibration-based feedback when predefined movement goals are achieved. Feedback conditions will target trailing limb angle, ankle plantarflexion, and trunk sway during walking.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking Speed
Time Frame: Single study visit (Day 1)

Walking speed measured during walking trials using timing gates and compared between baseline and vibrotactile feedback conditions.

Single study visit (Day 1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forward Propulsion
Time Frame: Single study visit (Day 1)

Maximum anterior ground reaction force measured during walking trials using force plate data and compared between baseline and vibrotactile feedback conditions.

Single study visit (Day 1)
Trailing Limb Angle
Time Frame: Single study visit (Day 1)

Trailing limb angle measured during walking trials using motion capture and wearable sensor data and compared between baseline and vibrotactile feedback conditions.

Single study visit (Day 1)
Ankle Plantarflexion Angle
Time Frame: Single study visit (Day 1)

Peak ankle plantarflexion angle measured during walking trials using motion capture and wearable sensor data and compared between baseline and vibrotactile feedback conditions.

Single study visit (Day 1)
Gait Symmetry
Time Frame: Single study visit (Day 1)

Symmetry ratio calculated between limbs for trailing limb angle, ankle plantarflexion angle, and forward propulsion during walking trials.

Single study visit (Day 1)
Lateral Trunk Sway
Time Frame: Single study visit (Day 1)

Magnitude of lateral trunk sway measured during walking trials using motion capture and wearable sensor data and compared between baseline and vibrotactile feedback conditions.

Single study visit (Day 1)
Timed Up and Go Assessment
Time Frame: Single study visit (Day 1)

Performance on the Timed Up and Go assessment collected during the study visit and used to explore relationships between clinical mobility measures and wearable sensor measurements.

Single study visit (Day 1)
Berg Balance Scale Assessment
Time Frame: Single study visit (Day 1)

Performance on the Berg Balance Scale assessment collected during the study visit and used to explore relationships between clinical balance measures and wearable sensor measurements

Single study visit (Day 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Ryan Roza, MD, Geisinger Clinic
  • Study Director: Margo Donlin, PhD, Bucknell University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

September 10, 2026

First Submitted That Met QC Criteria

September 15, 2026

First Posted (Actual)

September 21, 2026

Study Record Updates

Last Update Posted (Actual)

September 21, 2026

Last Update Submitted That Met QC Criteria

September 15, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified individual participant data that underlie the results reported in publications may be shared with qualified researchers for future research purposes.

IPD Sharing Time Frame

Beginning after publication of the primary study results and continuing for up to six years following study completion.

IPD Sharing Access Criteria

Access may be provided to qualified researchers for IRB-approved secondary analyses. Only deidentified data will be shared.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe